Scripcariu IS

No ORCID on file · 5 papers in corpus · active 2019-2023

Study types

  • article 1

Condition tags

  • adenomyosis 1
2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13020177

Background: Follitropin delta is the third recombinant human follicle-stimulating hormone (r-hFSH) expressed in a host cell line of human fetal retinal origin that currently emphasizes that the actual tendency of administration is a persona…

2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12123166

The urachus is an embryologic remnant of the cloaca that usually degenerates after birth, resulting from the obliteration of the allantois, whose role is to connect the bladder to the umbilicus. Incomplete removal of the lumen may give rise…

article 2021
Experimental and therapeutic medicine ·doi:10.3892/etm.2021.10696

The rapid development achieved over the last decades in volume rendering of ultrasound data, known as three-dimensional (3D) ultrasound technique, leads to new opportunities for refining the diagnosis in many gynaecologic conditions. The ai…

2021
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina57020083

Background and Objectives: The most utilized approach for the embolization of uterine arteries is the transfemoral path. However, the transradial approach (TRA) has been gaining popularity among cardiologic interventions in the last years b…

2019
Medicine ·doi:10.1097/md.0000000000016069

The aim of this study was to check whether the sFlt-1/PIGF ratio, established as the biomarker for preeclampsia, reduces the false positive rate of late fetal growth restriction (FGR) detection by ultrasound biometry.This was a prospective …